ArticleTuberculosis research and treatment2013

Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis.

Hyejin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.